Avastin (bevacizumab)

This information is intended for HCP only. This is a prescription based drug. Please consult your doctor if you need more information.

Avastin is a monoclonal antibody that targets vascular endothelial growth factor A (VEGF-A).

Avastin became the first anti-angiogenic therapy made widely available for the treatment of patients with an advanced cancer.

M-PK-00001196

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country.Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.

ContactLocationslinkedinfacebooktwitterinstagramyoutubeAbout RochePharma solutionsStoriesRoche careersPrivacy StatementLegal Statement